KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2016 - 2025)

Biomarin Pharmaceutical's Asset Utilization Ratio history spans 16 years, with the latest figure at 0.42 for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 2.71% year-over-year to 0.42, compared with a TTM value of 0.42 through Dec 2025, up 2.71%, and an annual FY2025 reading of 0.44, up 7.05% over the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.42 at Biomarin Pharmaceutical, up from 0.41 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.42 in Q4 2025, with the low at 0.31 in Q4 2021.
  • Average Asset Utilization Ratio over 5 years is 0.36, with a median of 0.35 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio dropped 17.48% in 2021 and then rose 15.92% in 2024.
  • Tracing BMRN's Asset Utilization Ratio over 5 years: stood at 0.31 in 2021, then increased by 7.63% to 0.33 in 2022, then rose by 7.27% to 0.36 in 2023, then increased by 15.92% to 0.41 in 2024, then rose by 2.71% to 0.42 in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Asset Utilization Ratio are 0.42 (Q4 2025), 0.41 (Q3 2025), and 0.42 (Q2 2025).